Restricted Access

You must be logged in to view this content.

TGA approves AciVision to treat ocular herpes

$currentPage/@nodeName

By Rhiannon Riches
Communications Manager

 

AciVision (Aciclovir) 3% (30mg/g) eye ointment 4.5g has received Therapeutic Goods Administration (TGA) approval for topical application for treatment of ocular herpes.

Optometry Australia understands that an ongoing supply will be available in Australia in the coming weeks.

This follows an announcement that Zovirax (Aciclovir) 3% eye ointment 4.5g, will cease production.

GlaxoSmithKline Australia, the manufacturer of Zovirax (Aciclovir), advised Optometry Australia that stocks in Australia are estimated to last until approximately December 2018.

AciVision is not currently listed on the PBS.



Like us on Facebook




Subscribe to our News RSS Feed

Latest Tweets




Recent Comments